Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
340
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
-4.53M
-
Total reported value, excl. options
-
$953M
-
Value change
-
-$44.1M
-
Put/Call ratio
-
1.52
-
Number of buys
-
164
-
Number of sells
-
-152
-
Price
-
$7.73
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q3 2025
440 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 340 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 176M outstanding shares and own 70.15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21.9M shares), BlackRock, Inc. (13.9M shares), RENAISSANCE TECHNOLOGIES LLC (8.18M shares), DIMENSIONAL FUND ADVISORS LP (6.89M shares), Point72 Asset Management, L.P. (5.76M shares), STATE STREET CORP (4.66M shares), GEODE CAPITAL MANAGEMENT, LLC (4.17M shares), MORGAN STANLEY (3.6M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (2.54M shares), and GOLDMAN SACHS GROUP INC (2.52M shares).
This table shows the top 340 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.